Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Gabriela Pavlasova, Marek Borsky, Veronika Svobodova, Jan Oppelt, Katerina Cerna, Jitka Novotna, Vaclav Seda, Miloslava Fojtova, Jiri Fajkus, Yvona Brychtova, Michael Doubek, Sarka Pospisilova, Jiri Mayer, Marek Mraz

Journal title: Leukemia

Journal number: 32/9

Journal publisher: Nature Publishing Group

Published year: 2018

Published pages: 2028-2031

DOI identifier: 10.1038/s41375-018-0211-0

ISSN: 0887-6924